HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	132.45B
Revenue (ttm)	129.68B
Net Income (ttm)	-3.14B
Shares Out	30.00M
EPS (ttm)	-104.67
PE Ratio	10.64
Forward PE	7.24
Dividend	35.00 (0.79%)
Ex-Dividend Date	Dec 27, 2024

Volume	30,717
Average Volume	58,505
Open	4,465.00
Previous Close	4,410.00
Day's Range	4,390.00 - 4,465.00
52-Week Range	3,825.00 - 5,420.00
Beta	0.83
RSI	50.44
Earnings Date	Feb 4, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 341
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.